Beurs gesloten -
Toronto S.E.
21:59:59 17-07-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
9,1
CAD
|
-0,55%
|
|
+12,62%
|
-39,97%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
129,1
|
192,3
|
114,4
|
252,1
|
302,9
|
181,7
|
-
|
-
|
Bedrijfswaarde
1 |
129,1
|
192,3
|
114,4
|
252,1
|
302,9
|
181,7
|
181,7
|
181,7
|
K/w-verhouding
|
-10,1
x
|
-9,8
x
|
-6,57
x
|
-10,7
x
|
-18,7
x
|
13,1
x
|
11,3
x
|
3,74
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
1.131
x
|
-
|
164
x
|
14,3
x
|
2,89
x
|
2,7
x
|
1,92
x
|
Bedrijfswaarde/omzet
|
-
|
1.131
x
|
-
|
164
x
|
14,3
x
|
2,89
x
|
2,7
x
|
1,92
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
-
|
-
|
7,48
x
|
4,58
x
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-17,7
x
|
11,1
x
|
13,6
x
|
39,8
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-5,66%
|
9,02%
|
7,35%
|
2,51%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
19.896
|
25.810
|
26.007
|
26.261
|
26.994
|
27.328
|
-
|
-
|
Referentieprijs
2 |
6,490
|
7,450
|
4,400
|
9,600
|
11,22
|
6,650
|
6,650
|
6,650
|
Datum van publicatie
|
14/02/20
|
30/03/21
|
28/02/22
|
29/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
0,17
|
-
|
1,535
|
21,25
|
62,94
|
67,21
|
94,58
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
24,3
|
39,7
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-13,01
|
-17,88
|
-17,22
|
-22,59
|
-12,77
|
17,03
|
18,24
|
50,3
|
Operationele Marge
|
-
|
-10.520,59%
|
-
|
-1.471,6%
|
-60,09%
|
27,06%
|
27,14%
|
53,18%
|
Resultaat voor belastingen (EBT)
1 |
-12,78
|
-18,11
|
-17,35
|
-23,71
|
-12,77
|
13,66
|
12,96
|
44,35
|
Nettowinst (verlies)
1 |
-12,78
|
-18,11
|
-17,35
|
-23,71
|
-16,04
|
14,56
|
16,38
|
48,67
|
Nettomarge
|
-
|
-10.652,35%
|
-
|
-1.544,89%
|
-75,5%
|
23,14%
|
24,37%
|
51,46%
|
WPA
2 |
-0,6400
|
-0,7600
|
-0,6700
|
-0,9000
|
-0,6000
|
0,5083
|
0,5883
|
1,777
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-17,14
|
16,4
|
13,36
|
4,567
|
FCF-marge
|
-
|
-
|
-
|
-
|
-80,67%
|
26,06%
|
19,88%
|
4,83%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
67,49%
|
33,66%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
112,62%
|
81,59%
|
9,38%
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
14/02/20
|
30/03/21
|
28/02/22
|
29/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
-
|
-
|
-
|
-
|
1,535
|
1,677
|
3,325
|
6,515
|
9,735
|
25,38
|
11,05
|
11,95
|
14,56
|
16,26
|
15,82
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0,4
|
3
|
5,5
|
15
|
7,3
|
Bedrijfsresultaat (EBIT)
1 |
-4,207
|
-3,546
|
-5,009
|
-7,899
|
-6,135
|
-5,27
|
-4,666
|
-1,017
|
-1,818
|
13,74
|
-0,2532
|
0,7737
|
2,776
|
4,958
|
1,82
|
Operationele Marge
|
-
|
-
|
-
|
-
|
-399,67%
|
-314,25%
|
-140,33%
|
-15,61%
|
-18,67%
|
54,16%
|
-2,29%
|
6,48%
|
19,06%
|
30,5%
|
11,51%
|
Resultaat voor belastingen (EBT)
1 |
-4,427
|
-3,696
|
-5,072
|
-8,089
|
-6,857
|
-6,052
|
-5,444
|
-1,867
|
-1,818
|
12,84
|
-0,7572
|
-0,285
|
1,85
|
4,096
|
1,008
|
Nettowinst (verlies)
1 |
-4,427
|
-3,696
|
-5,072
|
-8,089
|
-6,857
|
-6,052
|
-5,444
|
-1,867
|
-2,682
|
12,84
|
-0,822
|
0,245
|
2,292
|
3,696
|
0,808
|
Nettomarge
|
-
|
-
|
-
|
-
|
-446,71%
|
-360,88%
|
-163,73%
|
-28,66%
|
-27,55%
|
50,59%
|
-7,44%
|
2,05%
|
15,74%
|
22,74%
|
5,11%
|
WPA
2 |
-0,1800
|
-0,1400
|
-0,1900
|
-0,3100
|
-0,2600
|
-0,2300
|
-0,2100
|
-0,0700
|
-0,1000
|
0,4100
|
-0,0300
|
0,006670
|
0,0817
|
0,1125
|
0,0875
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28/02/22
|
12/05/22
|
12/08/22
|
11/11/22
|
29/03/23
|
11/05/23
|
3/08/23
|
6/11/23
|
21/03/24
|
14/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-17,1
|
16,4
|
13,4
|
4,57
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
14/02/20
|
30/03/21
|
28/02/22
|
29/03/23
|
21/03/24
|
-
|
-
|
-
|
Laatste slotkoers
6,65
USD Gemiddelde koersdoel
16,83
USD Spread / Gemiddelde doel +153,13% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +20,03% | 126 mld. | | +23,61% | 117 mld. | | +22,77% | 27,52 mld. | | -18,07% | 20,87 mld. | | -14,36% | 17,01 mld. | | -14,81% | 16,26 mld. | | +9,78% | 14,56 mld. | | -46,10% | 15,09 mld. | | +52,34% | 13,89 mld. |
Biotherapeutische geneesmiddelen
|